Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents

Published:2010-04-01 Issue:12 Volume:17 Page:1117-1124
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Lu X.-L.,Cao X.,Liu X.-Y.,Jiao B.-H.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational design of cyclic peptides to inhibit protein-peptide interactions;Biophysical Chemistry;2023-05

2. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis;Biochemical and Biophysical Research Communications;2021-04

3. The Relevance of the SH2 Domain for c-Src Functionality in Triple-Negative Breast Cancer Cells;Cancers;2021-01-26

4. Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer;Bioorganic & Medicinal Chemistry Letters;2016-02

5. Regions outside of conserved PxxPxR motifs drive the high affinity interaction of GRB2 with SH3 domain ligands;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2015-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP